Detecting and controlling diabetic nephropathy: what do we know?
review · Level V
Where this comes from
- Record sourced from PubMed, PMID 23547091.
- Also identified by DOI 10.3949/ccjm.80gr.12006.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Diabetic nephropathy is becoming increasingly common with the aging of our population and the obesity epidemic. The major ways to prevent or slow its progression are by reducing blood pressure, controlling blood sugar, and inhibiting the renin-angiotensin-aldosterone axis. New therapeutic agents are also being tried.
Medical subject headings
- Angiotensin Receptor Antagonists
- Angiotensin-Converting Enzyme Inhibitors
- Diabetes Mellitus, Type 2
- Diabetic Nephropathies
- Hypoglycemic Agents